1. Early Breast Cancer Trialists’ Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75 000 women. Lancet 339:1–15, 71–85
2. Fisher B, Brown AM, Dimitrov NV et al. (1990) Two months of doxorubicin- cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate and fluorouracil in positive-node breast cancer patients with tamoxifen-noresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project 13–15. J Clin Oncol 8: 2483–2496
3. Buzzoni R, Bonadonna G, Valagussa P et al. (1991) Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. J Clin Oncol 9:2134–2140
4. Bonadonna G, Valagussa P, Zambetti A et al. (1992) Sequential Adriamycin (ADM)-CMF in the adjuvant treatment of breast cancer with more than 3 positive axillary nodes. Proc Am Soc Clin Oncol 11:61